levamisole
Also known as Ergamisol®, R-12564, (S)-(-)-tetramisole, (-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole, (-)-tetramisole, (S)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole, (-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole, (S)-(-)-levamisole
Levamisole, sold under the brand name Ergamisol among others, is a medication used to treat parasitic worm infections, specifically ascariasis and hookworm infections. It is taken by mouth.
Key facts
- Drug.image
- Levamisole.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 180
- Drug.alt
- Skeletal formula of levamisole
- Drug.image2
- Levamisole molecule ball.png
- Drug.image_class2
- bg-transparent
- Drug.alt2
- Ball-and-stick model of the levamisole molecule
- Drug.tradename
- Ergamisol, others
- Drug.MedlinePlus
- a697011
- Drug.DailyMedID
- Levamisole
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
- P02
- Drug.ATC_suffix
Article
13 sectionsContents
- Medical uses
- Worms
- Other
- Adverse effects
- Metabolism
- Detection in body fluids
- Adulterant in illegal drugs
- Chemistry
- Toxicity
- Laboratory use
- Research
- Veterinary uses
- References
Levamisole, sold under the brand name Ergamisol among others, is a medication used to treat parasitic worm infections, specifically ascariasis and hookworm infections. It is taken by mouth.
Side effects may include abdominal pain, vomiting, headache, and dizziness. Use is not recommended during breastfeeding or the third trimester of pregnancy. Serious side effects may include an increased risk of infection. It belongs to the anthelmintic class of medications.